☰

Bruno Figueroa, Ph.D. - Publications

Affiliations: 
2002 Johns Hopkins University, Baltimore, MD 
Area:
Chemical Engineering, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lieske PL, Wei W, Crowe KB, Figueroa B, Zhang L. HIF-1 Signaling Pathway Implicated in Phenotypic Instability in a Chinese Hamster Ovary Production Cell Line. Biotechnology Journal. e1900306. PMID 31872551 DOI: 10.1002/biot.201900306  0.417
2019 Morrison C, Bandara K, Wang W, Zhang L, Figueroa B. Improvement of growth rates through nucleoside media supplementation of CHO clones. Cytotechnology. PMID 31115721 DOI: 10.1007/s10616-019-00319-0  0.311
2018 Lin TJ, Beal KM, Brown PW, DeGruttola HS, Ly M, Wang W, Chu CH, Dufield RL, Casperson GF, Carroll JA, Friese OV, Figueroa B, Marzilli LA, Anderson K, Rouse JC. Evolution of a comprehensive, orthogonal approach to sequence variant analysis for biotherapeutics. Mabs. PMID 30303443 DOI: 10.1080/19420862.2018.1531965  0.487
2018 Zhong X, Ma W, Meade CL, Tam AS, Llewellyn E, Cornell R, Cote K, Scarcelli JJ, Marshall JK, Tzvetkova B, Figueroa B, DiNino D, Sievers A, Lee C, Guo J, et al. A Transient CHO Expression Platform for Robust Antibody Production and Its Enhanced N-Glycan Sialylation on Therapeutic Glycoproteins. Biotechnology Progress. PMID 30299005 DOI: 10.1002/btpr.2724  0.314
2018 Scarcelli JJ, Hone M, Beal K, Ortega A, Figueroa B, Starkey JA, Anderson K. Analytical subcloning of a clonal cell line demonstrates sequence heterogeneity that does not impact process consistency or robustness. Biotechnology Progress. PMID 29693321 DOI: 10.1002/btpr.2646  0.365
2007 Figueroa B, Ailor E, Osborne D, Hardwick JM, Reff M, Betenbaugh MJ. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnology and Bioengineering. 97: 877-92. PMID 17099908 DOI: 10.1002/Bit.21222  0.691
2006 Sauerwald TM, Figueroa B, Hardwick JM, Oyler GA, Betenbaugh MJ. Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures. Biotechnology and Bioengineering. 94: 362-72. PMID 16598795 DOI: 10.1002/Bit.20874  0.658
2005 Wang X, Wang H, Figueroa BE, Zhang WH, Huo C, Guan Y, Zhang Y, Bruey JM, Reed JC, Friedlander RM. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11645-54. PMID 16354923 DOI: 10.1523/Jneurosci.4181-05.2005  0.42
2004 Figueroa B, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnology and Bioengineering. 85: 589-600. PMID 14966800 DOI: 10.1002/Bit.10913  0.76
2003 Figueroa B, Sauerwald TM, Oyler GA, Hardwick JM, Betenbaugh MJ. A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures. Metabolic Engineering. 5: 230-45. PMID 14642351 DOI: 10.1016/S1096-7176(03)00044-2  0.637
2001 Figueroa B, Sauerwald TM, Mastrangelo AJ, Hardwick JM, Betenbaugh MJ. Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults. Biotechnology and Bioengineering. 73: 211-22. PMID 11257603 DOI: 10.1002/Bit.1053  0.648
Show low-probability matches.